Eloxx Pharmaceuticals Inc Sustainability Reports
Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel RNA-modulating drug candidates. The company mainly develops small-molecule product candidates designed to treat rare and ultra-rare premature stop codon diseases.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 549300UB28QGWJMFFA11
No reports are currently available in our catalogue.